{"entity":{"type":"insider","cik":"0001266062","url":"/insider/0001266062","json_url":"/insider/0001266062.json","name":"BROWN MORGAN R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2004-02-04","last":"2020-12-17","span_basis":"filed_date"},"name_variants":[{"name":"BROWN MORGAN R","source":"filing","n_filings":7,"first_seen":"2004-02-04","last_seen":"2020-12-17"}],"transactions":[{"id":3200977,"accession":"0001638599-20-000976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001638599-20-000976","line_url":"/filing/0001638599-20-000976#line-2","is_derivative":false,"issuer_cik":"0001266062","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001266062","owner_cik":"0001266062","owner_name":"BROWN MORGAN R","owner_display_name":"BROWN MORGAN R","owner_url":"/insider/0001266062","role":"Officer (EVP and CFO)","role_mark":"O","role_mark_label":"Officer (EVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8437.0,"shares_display":"8,437","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":11389.95,"total_display":"11,389.95","total_whole":"11,390","shares_owned_after":194504.0,"shares_owned_after_display":"194,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-17","scope":"insider"},{"id":3063043,"accession":"0001638599-20-000948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001638599-20-000948","line_url":"/filing/0001638599-20-000948#line-2","is_derivative":false,"issuer_cik":"0001266062","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001266062","owner_cik":"0001266062","owner_name":"BROWN MORGAN R","owner_display_name":"BROWN MORGAN R","owner_url":"/insider/0001266062","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17250.0,"shares_display":"17,250","price_per_share":1.5666,"price_display":"1.57","price_state":"stated","total_value":27023.85,"total_display":"27,023.85","total_whole":"27,024","shares_owned_after":104062.0,"shares_owned_after_display":"104,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-08","scope":"insider"},{"id":7827662,"accession":"0001638599-19-001011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001638599-19-001011","line_url":"/filing/0001638599-19-001011#line-2","is_derivative":false,"issuer_cik":"0001266062","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001266062","owner_cik":"0001266062","owner_name":"BROWN MORGAN R","owner_display_name":"BROWN MORGAN R","owner_url":"/insider/0001266062","role":"Officer (EVP and Chief Financial Office)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Financial Office)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Financial Office","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17250.0,"shares_display":"17,250","price_per_share":0.4102,"price_display":"0.41","price_state":"stated","total_value":7075.95,"total_display":"7,075.95","total_whole":"7,076","shares_owned_after":63812.0,"shares_owned_after_display":"63,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-06","scope":"insider"},{"id":6741104,"accession":"0001638599-18-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001638599-18-000028","line_url":"/filing/0001638599-18-000028#line-2","is_derivative":false,"issuer_cik":"0001266062","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001266062","owner_cik":"0001266062","owner_name":"BROWN MORGAN R","owner_display_name":"BROWN MORGAN R","owner_url":"/insider/0001266062","role":"Officer (EVP and CFO)","role_mark":"O","role_mark_label":"Officer (EVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CFO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2813.0,"shares_display":"2,813","price_per_share":3.4744,"price_display":"3.47","price_state":"stated","total_value":9773.4872,"total_display":"9,773.49","total_whole":"9,773","shares_owned_after":23562.0,"shares_owned_after_display":"23,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2018-01-02","scope":"insider"},{"id":1269741,"accession":"0001266062-05-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266062-05-000002","line_url":"/filing/0001266062-05-000002#line-2","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001266062","owner_name":"BROWN MORGAN R","owner_display_name":"BROWN MORGAN R","owner_url":"/insider/0001266062","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":898.0,"shares_display":"898","price_per_share":16.191,"price_display":"16.19","price_state":"stated","total_value":14539.518,"total_display":"14,539.52","total_whole":"14,540","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-01","filed_date":"2005-02-02","scope":"insider"},{"id":633706,"accession":"0001266062-04-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266062-04-000003","line_url":"/filing/0001266062-04-000003#line-2","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001266062","owner_name":"BROWN MORGAN R","owner_display_name":"BROWN MORGAN R","owner_url":"/insider/0001266062","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":348.0,"shares_display":"348","price_per_share":17.95,"price_display":"17.95","price_state":"stated","total_value":6246.6,"total_display":"6,246.60","total_whole":"6,247","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-03","filed_date":"2004-08-04","scope":"insider"},{"id":625648,"accession":"0001266062-04-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266062-04-000001","line_url":"/filing/0001266062-04-000001#line-2","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001266062","owner_name":"BROWN MORGAN R","owner_display_name":"BROWN MORGAN R","owner_url":"/insider/0001266062","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":651.0,"shares_display":"651","price_per_share":32.989,"price_display":"32.99","price_state":"stated","total_value":21475.839,"total_display":"21,475.84","total_whole":"21,476","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-02-03","filed_date":"2004-02-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001535955","name":"Lipocine Inc.","url":"/issuer/0001535955","role":"Officer (EVP and CFO)","n_filings":4,"first_seen":"2018-01-02","last_seen":"2020-12-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000890465","name":"NPS PHARMACEUTICALS INC","url":"/issuer/0000890465","role":"Officer (Vice President, Finance)","n_filings":3,"first_seen":"2004-02-04","last_seen":"2005-02-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001266062","retrieved_at":"2026-08-25T08:35:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}